Início
Explorar
nav.journalClub
Tendências
Mais
synapse
⌘+K
Idioma
Português
Português
Clinical Outcomes Following Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The Endure Study | Synapse
March 3, 2026
Clinical Outcomes Following Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy in the United States: The Endure Study
MS
Michelle Long Schoettler
Emory University
AM
Andrew Messali
University of Southern California
QA
Qiana Amos
Optum (United States)
See all
Key Points
Clinical outcomes show a significant association with thrombotic microangiopathy, affecting recovery.
The analysis identified 45% of patients experienced vascular complications during the follow-up phase.
This observational analysis utilized a comprehensive dataset from multiple transplant centers across the U.S.
The findings highlight the need for further investigation to optimize management in hematopoietic stem cell transplant recipients.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Schoettler et al. (Sun,) studied this question.
synapsesocial.com/papers/69a760cec6e9836116a2de54
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.672
Mark Helpful
Like
Save
Bookmark
Relay
Share